Syngens
Syngens is a DNA design company on a mission to engineer and program life. They have developed an AI-powered DNA Design Platform that enables precise and predictable DNA engineering, specializing in multi-organism compatibility, advanced codon optimization, de novo DNA design and optimization, and novel pathway engineering and refactoring. Their platform aims to reduce experimentation by creating optimized DNA constructs tailored for specific biomanufacturing needs, allowing for computational testing and refinement of millions of designs to accelerate time-to-market and improve production efficiency. Syngens collaborates with various companies and academic institutions on grants related to synthetic biology, sustainable production, and AI-based DNA design.
Syngens
Syngens is a DNA design company on a mission to engineer and program life. They have developed an AI-powered DNA Design Platform that enables precise and predictable DNA engineering, specializing in multi-organism compatibility, advanced codon optimization, de novo DNA design and optimization, and novel pathway engineering and refactoring. Their platform aims to reduce experimentation by creating optimized DNA constructs tailored for specific biomanufacturing needs, allowing for computational testing and refinement of millions of designs to accelerate time-to-market and improve production efficiency. Syngens collaborates with various companies and academic institutions on grants related to synthetic biology, sustainable production, and AI-based DNA design.